AI assistant
Sending…
Editas Medicine, Inc. — Director's Dealing 2017
Jun 19, 2017
33260_dirs_2017-06-19_b6d40e6d-ee1a-4825-a188-2a0f37af3cbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2017-06-15
Reporting Person: Nikolic Boris (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-15 | Stock Option (right to buy) | $15.63 | A | 11538 | Acquired | 2027-06-14 | Common Stock (11538) | Direct |
Footnotes
F1: This option was granted on June 15, 2017 and is scheduled to vest in full on June 15, 2018.
More from Editas Medicine, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27